Hong Wei-Ju, Shieh Li-Tsun, Yen Ching-Yu, Lin Che-Yi, Chang Min-Te, Yu Hsi-Chien, Lin Chia-Hui, Lin Li-Ching, Ho Sheng-Yow
Department of Radiation Oncology, Chi Mei Medical Center, 901 Zhonghua Rd. Yongkang District, Tainan, 71004, Taiwan.
Department of Radiation Oncology, Chi Mei Medical Center, Liouying, Tainan, Taiwan.
Sci Rep. 2025 Apr 26;15(1):14618. doi: 10.1038/s41598-025-98222-6.
Oral cavity squamous cell carcinoma (SCC) is the most common head and neck region tumor. The pathologic T4a classification is defined tumor invasion by three distinctive subgroups with skin, bone marrow, or a depth of invasion (DOI) > 10 mm and tumor size > 40 mm, as specified in the revised AJCC 8th edition staging manual. We examined these three subgroups' different survival outcomes and explored factors influencing survival in patients with pT4a gingivobuccal SCC, and further investigate the discriminatory capacity among these three subgroups. All patients (n = 120) were treated from January 2010 to December 2021 for pT4a gingivobuccal SCC. Sixty-six (55%) exhibited bone invasion, 62 (51.7%) had skin invasion, and 44 (36.7%) had a deep DOI (DOI > 10 mm and tumor size > 40 mm). The median follow-up period for all patients was 93.6 months. The median overall survival (OS) was 48.1 months for patients with shallow (≤ 10 mm) vs. 25.1 months for those with deep DOIs (p = 0.03). The study found that deep DOI tumors were the primary factor influencing poorer OS in patients classified as pT4a after conducting a subgroup analysis. Three independent factors predicted poor prognosis: deep DOI (hazard ratio [HR] = 2.08, 95% confidence interval [CI] 1.00-4.31), extranodal extension (HR = 2.35, 95% CI 1.16-4.79), and positive resection margin (HR = 2.96, 95% CI 1.14-17.73). Deep DOI predicted worse outcomes and outperformed the risks of bone/skin invasion among these patients with pT4a gingivobuccal SCC.
口腔鳞状细胞癌(SCC)是头颈部最常见的肿瘤。根据美国癌症联合委员会(AJCC)第8版修订分期手册的规定,病理T4a分类定义为肿瘤侵犯分为三个不同亚组,即侵犯皮肤、骨髓,或浸润深度(DOI)>10mm且肿瘤大小>40mm。我们研究了这三个亚组不同的生存结局,并探讨了影响pT4a牙龈颊黏膜SCC患者生存的因素,进一步研究这三个亚组之间的鉴别能力。所有患者(n = 120)于2010年1月至2021年12月期间接受pT4a牙龈颊黏膜SCC治疗。66例(55%)表现为骨侵犯,62例(51.7%)有皮肤侵犯,44例(36.7%)有深部DOI(DOI>10mm且肿瘤大小>40mm)。所有患者的中位随访期为93.6个月。浅部(≤10mm)患者的中位总生存期(OS)为48.1个月,而深部DOI患者为25.1个月(p = 0.03)。该研究发现,在进行亚组分析后,深部DOI肿瘤是影响pT4a分类患者OS较差的主要因素。三个独立因素预示预后不良:深部DOI(风险比[HR]=2.08,95%置信区间[CI]1.00 - 4.31)、结外扩展(HR = 2.35,95%CI 1.16 - 4.79)和手术切缘阳性(HR = 2.96,95%CI 1.14 - 17.73)。深部DOI预示着更差的结局,并且在这些pT4a牙龈颊黏膜SCC患者中,其预后比骨/皮肤侵犯的风险更差。